OpenURL Connection Search

Select item for more details and to access through your institution.

A functional genomics approach to identify pathways of drug resistance in medulloblastoma.
Published in:
2018
By:
- Bertrand, Kelsey C.;
- Faria, Claudia C.;
- Skowron, Patryk;
- Luck, Amanda;
- Garzia, Livia;
- Wu, Xiaochong;
- Agnihotri, Sameer;
- Smith, Christian A.;
- Taylor, Michael D.;
- Mack, Stephen C.;
- Rutka, James T.
Publication type:
Letter
TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii34, doi. 10.1093/neuonc/nou208.43
By:
- Rutka, James;
- Park, Jun-Bum;
- Agnihotri, Sameer;
- Golbourn, Brian;
- Bertrand, Kelsey;
- Luck, Amanda;
- Sabha, Nesrin;
- Croul, Sidney;
- Smith, Christian A.
Publication type:
Article
FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii35, doi. 10.1093/neuonc/nou208.47
By:
- Smith, Christian;
- Faria, Claudia C.;
- Dubuc, Adrian M.;
- Remke, Marc;
- Golbourn, Brian J.;
- Diaz, Roberto J.;
- Agnihotri, Sameer;
- Luck, Amanda;
- Sabha, Nesrin;
- Olsen, Samantha;
- Wu, Xiaochong;
- Garzia, Livia;
- Ramaswamy, Vijay;
- Mack, Stephen C.;
- Wang, Xin;
- Leadley, Michael;
- Reynaud, Denis;
- Ermini, Leonardo;
- Post, Martin;
- Northcott, Paul A.
Publication type:
Article
A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma.
Published in:
Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad057
By:
- Ng, Chia Huan;
- Obrecht, Denise;
- Wells, Olivia;
- Zapotocky, Michal;
- Sumerauer, David;
- Coltin, Hallie;
- Khuong-Quang, Dong-Anh;
- Eisenstat, David D;
- Kinross, Kathryn M;
- White, Christine L;
- Algar, Elizabeth M;
- Luck, Amanda;
- Witt, Hendrik;
- Schüller, Ulrich;
- Mynarek, Martin;
- Pietsch, Torsten;
- Gerber, Nicolas U;
- Benesch, Martin;
- Warmuth-Metz, Monika;
- Kortmann, Rolf
Publication type:
Article
Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease.
Published in:
European Journal of Neuroscience, 2014, v. 39, n. 12, p. 2139, doi. 10.1111/ejn.12557
By:
- Hassiotis, Sofia;
- Beard, Helen;
- Luck, Amanda;
- Trim, Paul J.;
- King, Barbara;
- Snel, Marten F.;
- Hopwood, John J.;
- Hemsley, Kim M.
Publication type:
Article
Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.
Published in:
European Journal of Neuroscience, 2009, v. 29, n. 6, p. 1197, doi. 10.1111/j.1460-9568.2009.06666.x
By:
- Hemsley, Kim M.;
- Luck, Amanda J.;
- Crawley, Allison C.;
- Hassiotis, Sofia;
- Beard, Helen;
- King, Barbara;
- Rozek, Tomas;
- Rozaklis, Tina;
- Fuller, Maria;
- Hopwood, John J.
Publication type:
Article
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
Published in:
Neuro-Oncology, 2024, v. 26, n. 10, p. 1895, doi. 10.1093/neuonc/noae120
By:
- Golbourn, Brian;
- Ho, Ben;
- Bondoc, Andrew;
- Luck, Amanda;
- Fan, Xiaolian;
- Richardson, Elizabeth;
- Marcellus, Richard;
- Prakesch, Michael;
- Halbert, Mathew;
- Agrawal, Nishant;
- Smith, Christian;
- Huang, Annie;
- Rutka, James T
Publication type:
Article

Found: 7

A functional genomics approach to identify pathways of drug resistance in medulloblastoma.

TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY.

FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA.

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma.

Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease.

Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.

A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.